Jonn R. Beeson - Aug 15, 2023 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Stock symbol
XTNT
Transactions as of
Aug 15, 2023
Transactions value $
$0
Form type
4
Date filed
8/17/2023, 04:18 PM
Previous filing
May 16, 2023
Next filing
Aug 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock Award $0 +145K +278.93% $0.00 197K Aug 15, 2023 Direct F1, F2
holding XTNT Common Stock 1.02M Aug 15, 2023 The Platinum Legacy Trust, dated February 24, 2017, Jonn R. Beeson, Trustee

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XTNT Stock Option (right to buy) Award $0 +28.2K $0.00 28.2K Aug 15, 2023 Common Stock 28.2K $1.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are subject to a deferred stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.
F2 Includes 145,180 shares issuable upon settlement of deferred stock units granted under the Xtant Medial Holdings, Inc. 2023 Equity Incentive Plan and 52,049 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, all conditioned upon the Reporting Person remaining a director of Xtant through the vesting dates.
F3 This option vests on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.